<?xml version="1.0" encoding="UTF-8"?>
<ref id="A29052R11">
 <label>11</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Boberg</surname>
    <given-names>KM</given-names>
   </name>
   <name>
    <surname>Wisloff</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Kjollesdal</surname>
    <given-names>KS</given-names>
   </name>
   <name>
    <surname>Stovring</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Kristiansen</surname>
    <given-names>IS</given-names>
   </name>
  </person-group>
  <article-title>Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid.</article-title>
  <source>Aliment Pharmacol Ther.</source>
  <year>2013</year>
  <volume>38</volume>
  <issue>7</issue>
  <fpage>794</fpage>
  <lpage>803</lpage>
  <pub-id pub-id-type="doi">10.1111/apt.12435</pub-id>
  <?supplied-pmid 23915021?>
  <pub-id pub-id-type="pmid">23915021</pub-id>
 </element-citation>
</ref>
